
Omisafe Plus 1000mg/500mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Omisafe Plus 1000mg/500mg Injection
Combiflox 1000 mg/500 mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial for complete treatment, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) require emergency care. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Expectant or nursing mothers should seek medical advice. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment effectiveness.
Uses of Omisafe Plus 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Omisafe Plus 1000mg/500mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Omisafe Plus 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Omisafe Plus 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Omisafe Plus 1000mg/500mg Injection works:
Omisafe Plus, a 1000 mg/500 mg injectable formulation, unites Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam augments Ceftriaxone's effectiveness by countering bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Omisafe Plus 1000 mg/500 mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation Omisafe Plus (1000 mg/500 mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Omisafe Plus 1000 mg/500 mg Injection necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the system.
DrivingUNSAFE
The administration of Omisafe Plus 1000 mg/500 mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Omisafe Plus 1000 mg/500 mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 1000 mg/500 mg Omisafe Plus Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Omisafe Plus 1000 mg/500 mg Injection is not suggested for those with mild to moderate liver dysfunction.
What if you forget to take Omisafe Plus 1000mg/500mg Injection :
Should you inadvertently skip a dose of the Omisafe Plus 1000 mg/500 mg injection, seek medical advice.
Facts to Know About Omisafe Plus 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
